Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04276935 · ClinicalTrials.gov registry record
Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions
A clinical trial, sponsored by AIDS Malignancy Consortium.
- Completed
- Registry status
- 20
- Enrollment target
NCT04276935 is a clinical trial that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 20 participants.
The verdict
NCT04276935 has completed, sponsored by AIDS Malignancy Consortium.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This trial develops a health-related symptom index for participants with and either treated or monitored for anal high-grade squamous intraepithelial lesions. The health-related quality of life index may help to capture the symptoms and related experiences of living with or being treated for high-grade squamous intraepithelial lesions.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-11-06 |
| Est. Completion | 2020-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04276935
The ClinicalTrials.gov registry entry for NCT04276935 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AIDS Malignancy Consortium, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04276935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04276935 about?
NCT04276935 is a clinical study titled "Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions". This trial develops a health-related symptom index for participants with and either treated or monitored for anal high-grade squamous intraepithelial lesions. The health-related quality of life index may help to capture the symptoms and related experiences of living with or being treated for high-gr...
What is the current status of trial NCT04276935?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2018-11-06. Estimated completion is 2020-03-01.
What interventions are being tested in trial NCT04276935?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT04276935?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.